Otonomy Announces Assignment of J Code for OTIPRIO®

Back to Jobs

SAN DIEGO , Nov. 02, 2016 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that the Centers for Medicare and Medicaid Services (CMS)

Apply Now